Francisco Salva, Azitra CEO
A small Connecticut biotech throws hat into IPO ring
A biotech looking to treat skin diseases sent in word to the SEC that it wants to go public.
Azitra joins a relatively small group …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
